COVID19 HCPCS Value Sets

{
  "description" : "This is a collection of HCPCS value sets related to COVID-19. These value sets are curated by Clinical Architecture on behalf of CareEvolution, MITRE, SNOMED, and other COVID-19 Interoperability Alliance (https://covid19ia.org) collaborators.",
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.1005" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.1014" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.1017" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.1003" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.1008" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.1016" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.1001" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.1002" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.1009" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.1000" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.1011" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.1020" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.1010" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.1012" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.1015" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.1004" ]
    } ]
  },
  "date" : "2023-06-21T18:16:37-04:00",
  "meta" : {
    "versionId" : "28",
    "lastUpdated" : "2023-02-10T01:02:54.000-05:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "Clinical Architecture",
  "jurisdiction" : [ {
    "extension" : [ {
      "valueString" : "UNKNOWN",
      "url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason"
    } ]
  } ],
  "purpose" : "(Clinical Focus: Collection of HCPCS Value Sets related to COVID-19),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )",
  "name" : "COVID19HCPCSValueSets",
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "C9803",
      "display" : "Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "E0424",
      "display" : "Stationary compressed gaseous oxygen system, rental; includes container, contents, regulator, flowmeter, humidifier, nebulizer, cannula or mask, and tubing",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "E0431",
      "display" : "Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "E0434",
      "display" : "Portable liquid oxygen system, rental; includes portable container, supply reservoir, humidifier, flowmeter, refill adaptor, contents gauge, cannula or mask, and tubing",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "E0439",
      "display" : "Stationary liquid oxygen system, rental; includes container, contents, regulator, flowmeter, humidifier, nebulizer, cannula or mask, & tubing",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "E0441",
      "display" : "Stationary oxygen contents, gaseous, 1 month's supply = 1 unit",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "E0442",
      "display" : "Stationary oxygen contents, liquid, 1 month's supply = 1 unit",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "E0443",
      "display" : "Portable oxygen contents, gaseous, 1 month's supply = 1 unit",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "E0444",
      "display" : "Portable oxygen contents, liquid, 1 month's supply = 1 unit",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "E0445",
      "display" : "Oximeter device for measuring blood oxygen levels non-invasively",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "E0465",
      "display" : "Home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube)",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "E0466",
      "display" : "Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "E0470",
      "display" : "Respiratory assist device, bi-level pressure capability, without backup rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "E0471",
      "display" : "Respiratory assist device, bi-level pressure capability, with back-up rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "E0472",
      "display" : "Respiratory assist device, bi-level pressure capability, with backup rate feature, used with invasive interface, e.g., tracheostomy tube (intermittent assist device with continuous positive airway pressure device)",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "E0481",
      "display" : "Intrapulmonary percussive ventilation system and related accessories",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "E0482",
      "display" : "Cough stimulating device, alternating positive and negative airway pressure",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "E0483",
      "display" : "High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "E0484",
      "display" : "Oscillatory positive expiratory pressure device, non-electric, any type, each",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "E1390",
      "display" : "Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0108",
      "display" : "Diabetes outpatient self-management training services, individual, per 30 minutes",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0109",
      "display" : "Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0257",
      "display" : "Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0270",
      "display" : "Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0296",
      "display" : "Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making)",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0396",
      "display" : "Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0397",
      "display" : "Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0406",
      "display" : "Follow-up inpatient consultation, limited, physicians typically spend 15 minutes communicating with the patient via telehealth",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0407",
      "display" : "Follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0408",
      "display" : "Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0410",
      "display" : "Group psychotherapy other than of a multiple-family group, in a partial hospitalization setting, approximately 45 to 50 minutes",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0420",
      "display" : "Face-to-face educational services related to the care of chronic kidney disease; individual, per session, per one hour",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0421",
      "display" : "Face-to-face educational services related to the care of chronic kidney disease; group, per session, per one hour",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0425",
      "display" : "Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0426",
      "display" : "Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0427",
      "display" : "Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0438",
      "display" : "Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0439",
      "display" : "Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0442",
      "display" : "Annual alcohol misuse screening, 5 to 15 minutes",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0443",
      "display" : "Brief face-to-face behavioral counseling for alcohol misuse, 15 minutes",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0444",
      "display" : "Annual depression screening, 5 to 15 minutes",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0445",
      "display" : "High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0446",
      "display" : "Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0447",
      "display" : "Face-to-face behavioral counseling for obesity, 15 minutes",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0459",
      "display" : "Inpatient telehealth pharmacologic management, including prescription, use, and review of medication with no more than minimal medical psychotherapy",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0498",
      "display" : "Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0506",
      "display" : "Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service)",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0508",
      "display" : "Telehealth consultation, critical care, initial , physicians typically spend 60 minutes communicating with the patient and providers via telehealth",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0509",
      "display" : "Telehealth consultation, critical care, subsequent, physicians typically spend 50 minutes communicating with the patient and providers via telehealth",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0513",
      "display" : "Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; first 30 minutes (list separately in addition to code for preventive service)",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G0514",
      "display" : "Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; each additional 30 minutes (list separately in addition to code g0513 for additional 30 minutes of preventive service)",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G2023",
      "display" : "Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G2024",
      "display" : "Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G2086",
      "display" : "Office-based treatment for opioid use disorder, including development of the treatment plan, care coordination, individual therapy and group therapy and counseling; at least 70 minutes in the first calendar month",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G2087",
      "display" : "Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G2088",
      "display" : "Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; each additional 30 minutes beyond the first 120 minutes (list separately in addition to code for primary procedure)",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "G9685",
      "display" : "Physician service or other qualified health care professional for the evaluation and management of a beneficiary's acute change in condition in a nursing facility. this service is for a demonstration project",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "J3262",
      "display" : "Injection, tocilizumab, 1 mg",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "J9030",
      "display" : "Bcg live intravesical instillation, 1 mg",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "K0738",
      "display" : "Portable gaseous oxygen system, rental; home compressor used to fill portable oxygen cylinders; includes portable containers, regulator, flowmeter, humidifier, cannula or mask, and tubing",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "M0201",
      "display" : "Covid-19 vaccine administration inside a patient's home; reported only once per individual home per date of service when only covid-19 vaccine administration is performed at the patient's home",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "M0240",
      "display" : "Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "M0241",
      "display" : "Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency, subsequent repeat doses",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "M0243",
      "display" : "Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "M0244",
      "display" : "Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "M0245",
      "display" : "Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "M0246",
      "display" : "Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider based to the hospital during the covid 19 public health emergency",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "M0247",
      "display" : "Intravenous infusion, sotrovimab, includes infusion and post administration monitoring",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "M0248",
      "display" : "Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "M0249",
      "display" : "Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "M0250",
      "display" : "Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "Q0083",
      "display" : "Chemotherapy administration by other than infusion technique only (e.g., subcutaneous, intramuscular, push), per visit",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "Q0084",
      "display" : "Chemotherapy administration by infusion technique only, per visit",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "Q0085",
      "display" : "Chemotherapy administration by both infusion technique and other technique(s) (e.g., subcutaneous, intramuscular, push), per visit",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "Q0240",
      "display" : "Injection, casirivimab and imdevimab, 600 mg",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "Q0243",
      "display" : "Injection, casirivimab and imdevimab, 2400 mg",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "Q0244",
      "display" : "Injection, casirivimab and imdevimab, 1200 mg",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "Q0245",
      "display" : "Injection, bamlanivimab and etesevimab, 2100 mg",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "Q0247",
      "display" : "Injection, sotrovimab, 500 mg",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "Q0249",
      "display" : "Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "S2065",
      "display" : "Simultaneous pancreas kidney transplantation",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "S9152",
      "display" : "Speech therapy, re-evaluation",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "S9329",
      "display" : "Home infusion therapy, chemotherapy infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code with s9330 or s9331)",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "S9330",
      "display" : "Home infusion therapy, continuous (twenty-four hours or more) chemotherapy infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "S9331",
      "display" : "Home infusion therapy, intermittent (less than twenty-four hours) chemotherapy infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "U0001",
      "display" : "Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "U0002",
      "display" : "2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "U0003",
      "display" : "Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "U0004",
      "display" : "2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r",
      "version" : "2023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "code" : "U0005",
      "display" : "Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2",
      "version" : "2023"
    } ],
    "offset" : 0,
    "total" : 90,
    "identifier" : "urn:uuid:6e8e5eb7-ccf9-4c50-81c8-263846afcd56",
    "timestamp" : "2023-06-29T16:37:47-04:00",
    "parameter" : [ {
      "name" : "count",
      "valueInteger" : 1000
    }, {
      "name" : "offset",
      "valueInteger" : 0
    } ]
  },
  "title" : "COVID19 HCPCS Value Sets",
  "extension" : [ {
    "valueString" : "Clinical Architecture",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueDate" : "2023-06-21",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2023-02-10",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "active",
  "id" : "0ceffca6-5c76-4c3b-9afd-e8389a2e672a",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.7000",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.3.3616.200.110.102.7000"
  } ],
  "version" : "20230210"
}